KING PHARMACEUTICALS INC Uncategorized Contracts & Agreements
25 Contracts & Agreements
- Financial Statements (Filed With SEC on May 6, 2010)
- Current Salary (Filed With SEC on March 23, 2010)
- Current Salary (Filed With SEC on March 23, 2010)
- Current Salary (Filed With SEC on March 23, 2010)
- Current Salary (Filed With SEC on March 23, 2010)
- Financial Statements (Filed With SEC on May 11, 2009)
- Financial Statements (Filed With SEC on May 11, 2009)
- Financial Statements (Filed With SEC on May 11, 2009)
- Financial Statements (Filed With SEC on May 11, 2009)
- Financial Statements (Filed With SEC on May 11, 2009)
- EX-10.1: AMENDED AND RESTATED COMMITMENT LETTER (Filed With SEC on November 24, 2008)
- METAXALONE 800 mg PRODUCT AGREEMENT (Filed With SEC on January 8, 2008)
- - 1 - (Filed With SEC on November 5, 2007)
- Ex-2.2 Side Letter among King and Ligand dated December 29, 2006 (Filed With SEC on January 5, 2007)
- Ex-10.4 Form of Restricted Unit Certificate/Grant Agreement (Filed With SEC on November 9, 2006)
- Ex-10.2 July 31, 2006 Settelement Agreement (Filed With SEC on November 9, 2006)
- Ex-10.1 Amended Co-Promotion Agreement (Filed With SEC on November 9, 2006)
- EX-10.2 FORM OF RESTRICTED UNIT CERTIFICATE AND RESTRICTED UNIT GRANT AGREEMENT (Filed With SEC on August 9, 2006)
- EX-10.1 PROMOTION AGREEMENT 06/27/06 (Filed With SEC on August 9, 2006)
- Ex-10.7 First Amendment to the US Product Agreement (Filed With SEC on May 10, 2006)
- Ex-10.6 Amended and Restated Manufacturing Agreement (Filed With SEC on May 10, 2006)
- Ex-10.5 Dismissal Agreement (Filed With SEC on May 10, 2006)
- Ex-10.2 Offer letter to Eric J. Bruce dated May 19, 2005 (Filed With SEC on August 9, 2005)
- Ex-10.1 Offer letter to Joseph Squicciarino dated May 6, 2005 (Filed With SEC on August 9, 2005)
- EX-2.1 Amended & Restated Asset Purch. Agreement (Filed With SEC on June 13, 2003)